Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicentre, multinational, randomised, double blind, double dummy, active drug controlled, parallel group study design clinical trial of the efficacy and tolerability of beclomethasone dipropionate 250 mcg [microg] plus salbutamol 100 mcg in HFA pMDI [hydroflurocarbons pressurized metered dose inhaler] fixed combination vs. beclomethasone dipropionate 250 mcg plus salbutamol 100 mcg in CFC pMDI [chloroflurocarbons] (Clenil compositum 250) fixed combination in a 12-week treatment period of adult patients with uncontrolled asthma

Next Previous
X
Search
Trial Profile

Multicentre, multinational, randomised, double blind, double dummy, active drug controlled, parallel group study design clinical trial of the efficacy and tolerability of beclomethasone dipropionate 250 mcg [microg] plus salbutamol 100 mcg in HFA pMDI [hydroflurocarbons pressurized metered dose inhaler] fixed combination vs. beclomethasone dipropionate 250 mcg plus salbutamol 100 mcg in CFC pMDI [chloroflurocarbons] (Clenil compositum 250) fixed combination in a 12-week treatment period of adult patients with uncontrolled asthma

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Salbutamol/beclometasone (Primary)
  • Indications Asthma
  • Focus Therapeutic Use

    • Most Recent Events

    • 30 Mar 2017 Biomarkers information updated
    • 06 Nov 2012 Planned number of patients changed from 180 to 282.
    • 23 Apr 2010 Additional trial location (Russia) identified as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top